Integrated Application of Transcriptomics and Metabolomics Provides Insights into the Different Body-Size Growth in Chinese Mitten Crab ().

The Chinese mitten crab, , is a water-dwelling crustacean that is widely distributed in northern hemisphere water systems. Body size is one of the crucial indicators determining the economic value of . However, research on the genetic basis and regulatory mechanisms of body size in this species is limited, with only a few relevant genes reported. Therefore, it is imperative to investigate the regulatory pathways associated with its growth. This study first utilized transcriptomic profiling and metabolomic sequencing to construct gene expression profiles and metabolite profiles of of different body sizes. Subsequently, through integrated omics analysis, the key genes and regulatory pathways involved in controlling the growth and size of crabs were preliminarily identified. This study found that larger female crabs exhibited significantly enhanced digestive functions, primarily reflected in the upregulation of expression, suggesting its potentially pivotal role in regulating the growth and development of crabs. Interestingly, a variety of tissue-specific proteins such as APOLPP, RICK A, AGMO, and NEPHRIN, as well as REXO1L1P and ZCCHC24, indirectly influence the growth and development of crabs through their respective functional pathways. In addition, the key KEGG pathways, such as ECM-receptor interaction, cell adhesion, and the PI3K-Akt signaling pathway, were revealed to play central roles in the growth regulation of . These findings expand our understanding of the growth regulation mechanisms in crustaceans and offer potential molecular targets for body-size improvement in aquaculture.